Table 4. Immunofluorescence studies in patients with APSGNa

Time from Onset to BiopsynNAPlrPlasminogenFibrinogenC3IgGIgAIgMPClqC4C5C9SMAC
a P, properdin; S, S protein (vitronectin); MAC, membrane attack complex; Percentages are reported in parentheses.
1–14 d2525/25 (100)10/25 (40)15/25 (60)25/25 (100)16/25 (64)11/25 (44)10/25 (40)23/25 (92)7/25 (28)8/25 (32)25/25 (100)24/25 (96)24/25 (96)25/25 (100)
15–30 d1811/18 (61)5/18 (28)11/18 (61)18/18 (100)11/18 (61)8/18 (44)9/18 (50)16/18 (89)6/18 (33)3/18 (17)18/18 (100)17/18 (94)17/18 (94)18/18 (100)
31–90 d70/7 (0)0/7 (0)4/7 (57)6/7 (86)3/7 (43)3/7 (43)3/7 (43)5/7 (71)2/7 (29)1/7 (14)6/7 (86)5/7 (71)5/7 (71)6/7 (86)
Total5036/50 (72)15/50 (30)30/50 (60)49/50 (98)30/50 (60)22/50 (44)22/50 (44)44/50 (88)15/50 (30)12/50 (24)49/50 (98)46/50 (92)46/50 (92)49/50 (98)